Sildenafil citrate (Viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits

Pediatric Research

Volumn 57, Issue 1, 2005, Pages 22-27

  Bremer, Yvonne A ^a   Salloum, Fadi ^b   Ockaili, Ramzi ^b   Chou, Eric ^b   Moskowitz, William B ^a   Kukreja, Rakesh C ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVANS BLUE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM;

ANIMAL MODEL; AORTA; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; MALE; MORPHOMETRICS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; AORTA; CARDIAC OUTPUT; ECHOCARDIOGRAPHY; EVANS BLUE; HEART; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; RABBITS; REPERFUSION INJURY; TIME FACTORS; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 11144341967     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000147736.27672.15     Document Type: Article

References (21)

1. Rafiee P, Shi Y, Pritchard KA Jr, Ogawa H, Eis AL, Komorowski RA, Fitzpatrick CM, Tweddell JS, Litwin SB, Mussatto K, Jaquiss RD, Baker JE 2003 Cellular redistribution of inducible Hsp70 protein in the human and rabbit heart in response to the stress of chronic hypoxia: role of protein kinases. J Biol Chem 278:43636-43644
2. Long WA, Kirklin JK 1990 Neonatal cardiopulmonary bypass. In: Lamsback WJ (ed) Fetal and Neonatal Cardiology. WB Saunders, Philadelphia, pp 736-741
3. Lewin MB, Dreyer WJ, Fisher DJ 1998 Pathophysiology of ischemic myocardial injury and methods of myocardial protection. In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR (eds) The Science and Practice of Pediatric Cardiology, 2nd Ed. Williams & Wilkins, Baltimore, pp 279-295
4. Wernovsky G, Chang AC, Wessel DL 2001 Intensive care. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ (eds) Moss and Adams' Heart Disease in Infants, Children, and Adolescents Including the Fetus and the Young Adult, 6th Ed. Lippincott Williams & Wilkins, Philadelphia, pp 350-381
5. Baker JE, Boerboom LE, Olinger GN 1988 Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium. J Thorac Cardiovasc Surg 96:717-724
6. Murry CE, Jennings RB, Reimer KA 1986 Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
7. Xi L, Tekin D, Gursoy E, Salloum F, Levasseur JE, Kukreja RC 2002 Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol 283:H5-H12
8. Xi L, Tekin D, Bhargava P, Kukreja RC 2001 Whole body hypothermia and preconditioning of the heart: basic concepts, complexity and potential mechanisms. Int J Hyperthermia 17:439-455
9. Zhao T, Xi L, Chelliah J, Levasseur JE, Kukreja RC 2000 Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A1 receptors: evidence from gene-knockout mice. Circulation 102:902-907
10. 2 receptor is involved in the late phase of preconditioning in rabbit heart. J Mol Cell Cardiol 33:1355-1362
11. ATP channel in rabbits. Am J Physiol Heart Circ Physiol 283:H1263-H1269
12. Kimball TR, Meyer RA 2001 Echocardiography. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ (eds) Moss and Adams' Heart Disease in Infants, Children, and Adolescents Including the Fetus and the Young Adult, 6th Ed. Lippincott Williams & Wilkins, Philadelphia, pp 204-233
13. Snider AR, Serwer GA 1990 Methods for obtaining quantitative information from the echocardiographic examination. In: Lampert RH, Thorp D (eds) Echocardiography in Pediatric Heart Disease. Mosby-Year Book, St. Louis, pp 78-133
14. Gillies HC, Roblin D, Jackson G 2002 Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease. Int J Cardiol 86:131-141
15. Sebkhi A, Strange JW, Phillips SC, Wharton J, Wilkins MR 2003 Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation 107:3230-3235
16. Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW 2001 Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104:1218-1222
17. Stiebellehner L, Petkov V, Vonbank K, Funk G, Schenk P, Ziesche R, Block LH 2003 Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 123:1293-1295
18. Kukreja RC, Ockaili R, Salloum F, Yin C, Hawkins J, Das A, Xi L 2004 Cardioprotection with phosphodiesterase-5 inhibition - a novel preconditioning strategy. J Mol Cell Cardiol 36:165-173
19. Salloum F, Yin C, Xi L, Kukreja RC 2003 Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 92:595-597
20. Das A, Ockaili R, Salloum F, Kukreja RC 2004 Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. Am J Physiol Heart Circ Physiol 286:H1455-H1460
21. Snider AR, Ritter SB 2001 Doppler echocardiography. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ (eds) Moss and Adams' Heart Disease in Infants, Children, and Adolescents Including the Fetus and the Young Adult, 6th Ed. Lippincott Williams & Wilkins, Philadelphia, pp 234-263